Effect of Mineral Trioxide Aggregate on Rat Clonal Dental Pulp Cells: Expression of Cyclooxygenase-2 mRNA and Inflammation-related Protein via Nuclear Factor Kappa B Signaling System

Journal of Endodontics

Volumn 35, Issue 6, 2009, Pages 843-846

  Minamikawa, Hajime ^a   Deyama, Yoshiaki ^a   Nakamura, Kouichi ^a   Yoshimura, Yoshitaka ^a   Kaga, Masayuki ^a   Suzuki, Kuniaki ^a   Yawaka, Yasutaka ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

COX 2; EIA; iNOS; mineral trioxide aggregate; NF B; PGE2; RPC C2A

Indexed keywords

ALUMINUM DERIVATIVE; CALCIUM DERIVATIVE; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; I KAPPA B; I KAPPA B BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MINERAL TRIOXIDE AGGREGATE; NOS2 PROTEIN, RAT; OXIDE; PROSTAGLANDIN E2; ROOT CANAL FILLING MATERIAL; SILICATE;

ACTIVE TRANSPORT; ANIMAL; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CHEMISTRY; DRUG ANTAGONISM; DRUG COMBINATION; DRUG EFFECT; GENE EXPRESSION REGULATION; METABOLISM; PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; TOOTH PULP;

ACTIVE TRANSPORT, CELL NUCLEUS; ALUMINUM COMPOUNDS; ANIMALS; CALCIUM COMPOUNDS; CELLS, CULTURED; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; DENTAL PULP; DINOPROSTONE; DRUG COMBINATIONS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; I-KAPPA B PROTEINS; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; OXIDES; PHOSPHORYLATION; RATS; ROOT CANAL FILLING MATERIALS; SIGNAL TRANSDUCTION; SILICATES;

EID: 65849209524     PISSN: 00992399     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joen.2009.03.008     Document Type: Article

References (35)

1. Adamo H.L., Buruiana R., Schertzer L., and Boylan R.J. A comparison of MTA, Super-EBA, composite and amalgam as root-end filling materials using a bacterial micro leakage model. Int Endod J 32 (1999) 197-203
2. Torabinejad M., and Chivian N. Clinical applications of mineral trioxide aggregate. J Endod 25 (1999) 197-205
3. Gartner A.H., and Dorn S.O. Advances in endodontic surgery. Dent Clin North Am 36 (1992) 357-378
4. Gorduysus M., Avcu N., Gorduysus O., et al. Cytotoxic effects of four different endodontic materials in human periodontal ligament fibroblasts. J Endod 33 (2007) 1450-1454
5. Huang T.H., Ding S.J., Hsu T.C., and Kao C.T. Effects of mineral trioxide aggregate (MTA) extracts on mitogen-activated protein kinase activity in human osteosarcoma cell line (U2OS). Biomaterials 24 (2003) 3909-3913
6. Koh E.T., McDonald F., Pitt Ford T.R., and Torabinejad M. Cellular response to mineral trioxide aggregate. J Endod 24 (1998) 543-547
7. Yoshimine Y., Ono M., and Akamine A. In vitro comparison of the biocompatibility of mineral trioxide aggregate, 4META/MMA-TBB resin, and intermediate restorative material as root-end-filling materials. J Endod 33 (2007) 1066-1069
8. Baeuerle P.A. Pro-inflammatory signaling: last pieces in the NF-κB puzzle?. Curr Biol 8 (1998) R19-R22
9. Xie Q.W., Kashiwabara Y., and Nathan C. Role of transcription factor NF-κB/Rel in induction of nitric oxide synthase. J Biol Chem 269 (1994) 4705-4708
10. Juan H. Prostaglandins as modulators of pain. Gen Pharmacol 9 (1978) 403-409
11. Samad T.A., Sapirstein A., and Woolf C.J. Prostanoids and pain: unraveling mechanisms and revealing therapeutic targets. Trends Mol Med 8 (2002) 390-396
12. Newton R., Kuitert L.M., Bergmann M., Adcock I.M., and Barnes P.J. Evidence for involvement of NF-κB in the transcriptional control of COX-2 gene expression by IL-1β. Biochem Biophys Res Commun 237 (1997) 28-32
13. Darville M.I., and Eizirik D.L. Regulation by cytokines of the inducible nitric oxide synthase promoter in insulin-producing cells. Diabetologia 41 (1998) 1101-1108
14. Smith W.L., DeWitt D.L., and Garavito R.M. Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem 69 (2000) 145-182
15. Suh N., Honda T., Finlay H.J., et al. Novel triterpenoids suppress inducible nitric oxide synthase (iNOS) and inducible cyclooxygenase (COX-2) in mouse macrophages. Cancer Res 58 (1998) 717-723
16. Kasugai S., Adachi M., and Ogura H. Establishment and characterization of a clonal cell line (RPC-C2A) from dental pulp of the rat incisor. Arch Oral Biol 33 (1988) 887-891
17. Chen J.J., Huang W.C., and Chen C.C. Transcriptional regulation of cyclooxygenase-2 in response to proteasome inhibitors involves reactive oxygen species-mediated signaling pathway and recruitment of CCAAT/enhancer-binding protein delta and CREB-binding protein. Mol Biol Cell 16 (2005) 5579-5591
18. Salvemini D., Misko T.P., Masferrer J.L., Seibert K., Currie M.G., and Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci U S A 90 (1993) 7240-7244
19. Wu M.H., Wang C.A., Lin C.C., Chen L.C., Chang W.C., and Tsai S.J. Distinct regulation of cyclooxygenase-2 by interleukin-1β in normal and endometriotic stromal cells. J Clin Endocrinol Metab 90 (2005) 286-295
20. Nanji A.A., Jokelainen K., Tipoe G.L., Rahemtulla A., Thomas P., and Dannenberg A.J. Curcumin prevents alcohol-induced liver disease in rats by inhibiting the expression of NF-κB-dependent genes. Am J Physiol Gastrointest Liver Physiol 284 (2003) G321-G327
21. Philip S., and Kundu G.C. Osteopontin induces nuclear factor κB-mediated promatrix metalloproteinase-2 activation through IκBα/IKK signaling pathways, and curcumin (diferulolylmethane) down-regulates these pathways. J Biol Chem 278 (2003) 14487-14497
22. Palmer R.M., Ferrige A.G., and Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327 (1987) 524-526
23. Moilanen E., Whittle B., and Moncada S. Nitric oxide as a factor in inflammation. In: Gallin J., and Snyderman R. (Eds). Inflammation: basic principles and clinical correlates (1999), Lippincott Williams & Wilkins, Philadelphia 787-800
24. Wu K.K. Inducible cyclooxygenase and nitric oxide synthase. Adv Pharmacol 33 (1995) 179-207
25. Ye Y., Martinez J.D., Perez-Polo R.J., Lin Y., Uretsky B.F., and Birnbaum Y. The role of eNOS, iNOS, and NF-κB in upregulation and activation of cyclooxygenase-2 and infact size reduction by atrovastin. Am J Phisiol Heart Circ Physiol 295 (2008) H343-H351
26. Baeuerle P.A., and Henkel T. Function and activation of NF-κB in the immune system. Annu Rev Immunol 12 (1994) 141-179
27. Blackwell T.S., and Christman J.W. The role of nuclear factor-κB in cytokine gene regulation. Am J Respir Cell Mol Biol 17 (1997) 3-9
28. Di Rosa M., Ialenti A., Ianaro A., and Sautebin L. Interaction between nitric oxide and cyclooxygenase pathways. Prostaglandins Leukot Essent Fatty Acids 54 (1996) 229-238
29. Melegari K.K., Botero T.M., and Holland G.R. Prostaglandin E production and viability of cells cultured in contact with freshly mixed endodontic materials. Int Endod J 39 (2006) 357-362
30. Coon D., Gulati A., Cowan C., and He J. The role of cyclooxygenase-2 (COX-2) in inflammatory bone resorption. J Endod 33 (2007) 432-436
31. Mada Y., Miyauchi M., Oka H., et al. Effects of endogenous and exogenous prostaglandin E2 on the proliferation and differentiation of a mouse cementoblast cell line (OCCM-30). J Periodontol 77 (2006) 2051-2058
32. Kuratate M., Yoshiba K., Shigetani Y., Yoshiba N., Ohshima H., and Okiji T. Immunohistochemical analysis of nestin, osteopontin, and proliferating cells in the reparative process of exposed dental pulp capped with mineral trioxide aggregate. J Endod 34 (2008) 970-974
33. Gomes-Filho J.E., de Faria M.D., Bernabé P.F., et al. Mineral trioxide aggregate but not light-cure mineral trioxide aggregate stimulated mineralization. J Endod 34 (2008) 62-65
34. Yasuda Y., Ogawa M., Arakawa T., Kadowaki T., and Saito T. The effect of mineral trioxide aggregate on the mineralization ability of rat dental pulp cells: an in vitro study. J Endod 34 (2008) 1057-1060
35. Tani-Ishii N., Hamada N., Watanabe K., Tujimoto Y., Teranaka T., and Umemoto T. Expression of bone extracellular matrix proteins on osteoblast cells in the presence of mineral trioxide. J Endod 33 (2007) 836-839